论文部分内容阅读
目的:分析随访管理干预对心脑血管疾病患者健康行为的影响,为更好地开展患者延续性管理提供参考。方法:选取2015年3月~2016年3月医院门诊收治的心脑血管疾病患者80例为研究对象,按照就诊顺序编号,采用数字随机表法分为对照组和观察组,每组40例。两组均予药物对症治疗,对照组采用常规医嘱+定期回院随诊,观察组采用随访管理干预进行跟踪管理。根据心脑血管疾病患者健康行为标准(不吸烟、BMI<25kg/m~2、体育锻炼次数、食盐摄入量),对两组就诊时和就诊后3个月的健康行为进行调查,比较两组就诊时、就诊3个月后患者健康行为的合格率。结果:两组就诊时健康行为四项合格率差异均无统计学意义。就诊3个月后,观察组的不吸烟率、BMI指数合格率、体育锻炼合格率和食盐摄入合格率均明显高于对照组(P<0.05)。结论:心脑血管疾病患者的健康行为对其病情发展极为关键,随访管理干预对提升心脑血管疾病患者健康行为合格率效果明显。
OBJECTIVE: To analyze the impact of follow-up management intervention on the health behaviors of patients with cardiovascular and cerebrovascular diseases, and to provide a reference for better continuity management of patients. Methods: Eighty patients with cardiovascular and cerebrovascular diseases admitted from the hospital from March 2015 to March 2016 were selected as the research objects, numbered according to the order of treatment and divided into control group and observation group with 40 cases in each group. The two groups were given symptomatic treatment of drugs, the control group using regular orders + regular follow-up back to the hospital, the observation group follow-up management intervention tracking management. According to the health and behavior standards of patients with cardiovascular and cerebrovascular diseases (non-smoking, BMI <25kg / m ~ 2, physical exercise times, salt intake), the two groups were investigated at the time of treatment and 3 months after treatment, At the time of group visit, the qualified rate of patients’ health behaviors after 3 months of treatment. Results: There was no significant difference in the four passing rates of health behaviors between the two groups. After 3 months of treatment, the non-smoking rate, passing rate of BMI index, pass rate of physical exercise and salt intake rate in the observation group were significantly higher than those in the control group (P <0.05). Conclusion: The health behavior of patients with cardiovascular and cerebrovascular diseases is very critical to the development of their disease. Follow-up management intervention is effective in improving the passing rate of health behaviors in patients with cardiovascular and cerebrovascular diseases.